A researcher who queried the Centers for Disease Control’s (CDC) Vaccine Adverse Event Reporting System (VAERS) discovered a 10,661.4% increase in cancer reports as a result of experimental COVID-19 gene-base vaccines as compared with all FDA-approved vaccines over the last 30 years.
Brian Shilhavy, who is the editor of Health Impact News, traced his steps in the search providing links to documentation of his various findings.
Having first queried the cases of “the most common cancers [that] had been reported following COVID-19 vaccines,” he found “837 cases of cancer, including 88 deaths, 66 permanent disabilities, and 104 life threatening events (Source).”
He emphasized that even these numbers were not exhaustive, and the VAERS database could not handle the larger search of “ALL cancers listed in VAERS” under this category of COVID inoculations.
“Using the exact same search terms for cancer,” he wrote, “I then searched ALL FDA-approved vaccines for the previous 30 years and found only 140 cases of cancer reported (Source).”
“That result is for 360 months (30 years), whereas the 837 cases following the experimental COVID-19 vaccines were reported in just 20 months, since the roll out of the COVID-19 shots beginning in December of 2020,” Shilhavy wrote.
“That is an increase of 10,661.4%!” he concluded.
Shilhavy, whose organization is located in Texas, also made note of the significant number of the cancer cases in the database that were of young people, from age 12 up through many young adults in their 20s.
Last October, a Swedish lab study found that the spike protein associated with the COVID-19 illness, and its experimental vaccines, enters the nucleus of cells and significantly interferes with DNA damage-repair functions, compromising a person’s adaptive immunity and perhaps encouraging the formation of cancer cells.